-
Idexx Laboratories Reports Q4 EPS of $0.62
Friday, January 28, 2011 - 8:11am | 56Idexx Laboratories (NASDAQ: IDXX) reports its Q4 diluted EPS at $0.62, versus the consensus of $0.55. IDXX reports its Q4 revenue at $238.8 million, versus the consensus of $279.22 million. IDXX shares fell 0.16% to $72.98 in after-hours trading. Read more from Benzinga's Company news.
-
Piper Jaffray Downgrades Thoratec To Neutral, PT To $27
Friday, January 28, 2011 - 8:02am | 28Piper Jaffray has downgraded Thoratec Corporation (NASDAQ: THOR) from Overweight to Neutral and has lowered the price target from $40 to $27.
-
Goldman Upgrades Medtronic To Buy, PT To $45
Friday, January 28, 2011 - 7:48am | 27Goldman Sachs has upgraded Medtronic, Inc. (NYSE: MDT) from Neutral to Buy and has raised the price target to $45.
-
RW Baird Downs THOR To Neutral
Friday, January 28, 2011 - 7:02am | 50Analysts at RW Baird downgrade Thoratec Corporation (NASDAQ: THOR) from “outperform” to “neutral.” The target price for THOR has been lowered from $41 to $28. THOR shares gained 1.12% to close at $26.13 yesterday. More Analyst Ratings here
-
Varian Posts a Mixed Bag, Ups View - Analyst Blog
Thursday, January 27, 2011 - 6:31pm | 795Leading integrated radiotherapy systems maker Varian Medical Systems (VAR) reported first-quarter fiscal 2011 (ended December 31) earnings per share from continuing operations of 80 cents, comfortably beating the Zacks Consensus Estimates of 73 cents and exceeding the corresponding year-ago...
-
Hearing U.S. Government Sues Boston Scientific Corporation (BSX)
Thursday, January 27, 2011 - 6:03pm | 18Hearing U.S. Government Sues Boston Scientific Corporation (NYSE: BSX).
-
Varian Posts a Mixed Bag, Ups View - Analyst Blog
Thursday, January 27, 2011 - 5:54pm | 795Leading integrated radiotherapy systems maker Varian Medical Systems (VAR) reported first-quarter fiscal 2011 (ended December 31) earnings per share from continuing operations of 80 cents, comfortably beating the Zacks Consensus Estimates of 73 cents and exceeding the corresponding year-ago...
-
ZOLL Medical Corporation Reports Q1 EPS of $.18 vs. $.16
Thursday, January 27, 2011 - 5:42pm | 114ZOLL Medical Corporation (Nasdaq: ZOLL) today announced that revenues for the first quarter of fiscal 2011 increased 8% to $113.2 million, compared to revenues in the first quarter of last year of $105.2 million. As previously disclosed, the first quarter of fiscal 2010 contained an extra week,...
-
ResMed Reports Q2 EPS of $.37 vs. $.36
Thursday, January 27, 2011 - 5:35pm | 90ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended December 31, 2010. Revenue for the quarter ended December 31, 2010 was $306.0 million, an 11% increase (a 14% increase on a constant currency basis) over the quarter ended December 31, 2009. For the quarter...
-
Accuray Announces Results for Second Quarter of Fiscal 2011
Thursday, January 27, 2011 - 5:20pm | 84Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the second quarter of fiscal year 2011, ended December 31, 2010. For the second quarter of fiscal 2011, Accuray reported total revenue of $54.2 million, a decrease of five percent from total revenue of $57.3 million during...
-
Cardica Reports Q2 EPS of $(0.13)
Thursday, January 27, 2011 - 5:19pm | 159Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal second quarter and six-months ended December 31, 2010. Total product sales were approximately $1.1 million for the fiscal 2011 second quarter compared to $1.0 million for the same period of fiscal 2010. Total net revenue...
-
Accuray Reports Q2 EPS of $.07 vs. $(0.01)
Thursday, January 27, 2011 - 5:10pm | 113Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the second quarter of fiscal year 2011, ended December 31, 2010. For the second quarter of fiscal 2011, Accuray reported total revenue of $54.2 million, a decrease of five percent from total revenue of $57.3 million during...
-
ResMed Inc. Announces Record Financial Results for the Quarter Ended and Six Months Ended December 31, 2010
Thursday, January 27, 2011 - 5:09pm | 90ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended December 31, 2010. Revenue for the quarter ended December 31, 2010 was $306.0 million, an 11% increase (a 14% increase on a constant currency basis) over the quarter ended December 31, 2009. For the quarter...
-
Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
Thursday, January 27, 2011 - 5:07pm | 120Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that revenues from continuing operations in fiscal 2010 increased 37 percent over those in fiscal 2009. Results from continuing...
-
Baxter Beats on EPS, Net Dips - Analyst Blog
Thursday, January 27, 2011 - 3:01pm | 1075Baxter International (BAX) reported fourth quarter and fiscal 2010 adjusted (excluding one-time items) earnings per share of $1.11 and $3.98, respectively, thereby beating the corresponding Zacks Consensus Estimates of $1.10 cents and $3.97, and surpassing the year-ago results of $1.03 and $3.80...